Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications
Jörg Tost(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Božena Smolková(Slovak Academy of Sciences), Gjorgji Madjarov(Ss. Cyril and Methodius University in Skopje), Maria Urbanova(Slovak Academy of Sciences), Verona Buociková(Cancer Research Institute of the Slovak Academy of Sciences), Georgína Kolníková(National Institute of Cardiovascular Diseases), Miljana Tanić(CRUK Lung Cancer Centre of Excellence), Juan Dubrot(Clinica Universidad de Navarra), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Peter Dubovan(Slovak Medical University), Riccardo Farinella(University of Pisa), Ján Strnádel(Comenius University Bratislava), Daniele Campa(University of Pisa), Julie Earl(Instituto Cajal), Miroslav Tomáš(Slovak Medical University), Marija Chaushevska(Ss. Cyril and Methodius University in Skopje), Agapi Kataki(National and Kapodistrian University of Athens), Seçil Ak-Aksoy(Bursa Uludağ Üni̇versi̇tesi̇), C Corradi(University of Pisa)
Cited by 8
Related Papers
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis
|The American Journal of Human Genetics|2016|921
DNA methylation analysis by pyrosequencing
|Nature Protocols|2007|623